tm
Seeing Is Believing
tm
Seeing Is Believing
NBY is currently covered by 1 analysts with an average price target of $37.21. This is a potential upside of $36.59 (5901.61%) from yesterday's end of day stock price of $0.62.
NovaBay Pharmaceuticals's activity chart (see below) currently has 0 price targets and 7 ratings on display. The stock rating distribution of NBY is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 91.5 days.
Highest price target for NBY is $21, Lowest price target is $21, average price target is $37.21.
Most recent stock forecast was given by JAY COHEN from LADENBURG on 11-Aug-2023. First documented stock forecast 16-Nov-2018.
Currently out of the existing stock ratings of NBY, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$3.8
$3.35 (744.44%)
1 years 4 months 24 days ago
(11-Aug-2023)
1/2 (50%)
$7.02 (252.09%)
183
Buy
2 years 7 months 15 days ago
(20-May-2022)
0/1 (0%)
$66.15 (170.27%)
What is NBY (NovaBay Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on NBY (NovaBay Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on NBY (NovaBay Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on NBY (NovaBay Pharmaceuticals)?
Which analyst is the currently most bullish on NBY (NovaBay Pharmaceuticals)?
Which analyst is the currently most reserved on NBY (NovaBay Pharmaceuticals)?
